CVS Caremark PBM will launch a new “guaranteed net cost” drug pricing model that will return 100% of rebates to health plan clients in a move to “predictability and pricing simplicity.”
Category: NYSE:CI
Move From Fee-For-Service Medicine Hits Hospital Profits Again
Fitch Ratings says “acute care operating profitability” is set to deteriorate for a third consecutive year for nonprofit hospitals and health systems.
Medicare Costs Drop As Humana Shifts Doctors To Value-Based Models
Medical costs were 15.6% lower for seniors enrolled in Humana Medicare Advantage plans that paid physicians via value-based models last year, the insurer said.
Anthem’s PBM On Track for 2020 Launch
Anthem said its own pharmacy benefit manager, IngenioRx, “remains on track” to launch Jan. 1, 2020.
Medicare Advantage’s Latest Benefit Helps Grandma Kick The Habit
Nearly half of Medicare Advantage plans are offering new supplement benefits for 2019 that range from nicotine replacement therapy to in-home support from a caregiver or social worker, Avalere Health says in a new report.
UnitedHealth Group’s Value-Based Care Spend Hits $69 Billion
UnitedHealth Group says it’s paying almost half of its reimbursements – or $69 billion – via value-based care models.
As Blue Wave Crests, Health Insurers Brace For ‘Medicare For All’ Push
An effort to derail Medicare for All proposals is underway by health insurance lobbies Blue Cross Blue Shield Association and America’s Health Insurance Plans.
As Open Enrollment Begins, Record Medicare Advantage Growth Expected
Seniors will see a 20% increase in the number of Medicare Advantage plan choices for 2019 when they begin open enrollment Oct. 15.
Rite Aid’s PBM Key To Any Revival
Rite Aid’s EnvisionRx PBM is targeting the booming business of aging baby boomers buying Medicare Part D drug plans.
Rite Aid Shakes Up Board, Strips CEO Of Chairmanship After Failed Merger
Rite Aid unveiled new governance, stripping CEO John Standley of the company’s chairmanship and adding new board members in the wake of a failed merger and mounting financial losses.
